183 results on '"McPartlin, Andrew"'
Search Results
2. Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer
3. A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer
4. Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem
5. Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy
6. First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer
7. MRL Prostate GTV Focal Boost: Is Prep Relevant?
8. GTV Boost for Prostate Cancer: Early Comparison of Patient-Reported QoL with MR-Linac vs HDR Brachytherapy
9. Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis
10. TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
11. Use of magnetic resonance imaging in radical prostate radiotherapy
12. Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model.
13. Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform
14. Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring
15. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial
16. Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based Model
17. 3 Plasma EBV DNA in Nasopharyngeal Cancer (NPC) Treated with Definitive Radiotherapy (RT)
18. 35 Outcomes Following Altered Fractionated Radiotherapy Alone in Patients with TNM-7 Stage III/ IV Head and Neck Squamous Cell Carcinoma (HNSCC)
19. 149 Accumulated Kidney Dose in Renal Stereotactic Body Radiotherapy: Analysis from a Prospective Phase II Trial
20. 2108: Initial clinical experience with GTV boost for prostate cancer using MR-Linac
21. 1300: Translation of Dynamic Contrast Enhanced MRI in Head and Neck Cancer to the MR Linac
22. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma
23. Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases
24. Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy
25. Dysphagia At 1 Year is Associated with Mean Dose to The Inferior Section of The Brainstem
26. Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study
27. TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
28. Corrigendum to “Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study” [Radiother. Oncol. 172 (2022) 111–117]
29. Larynx cancer survival model developed through open-source federated learning
30. Open-source distributed learning validation for a larynx cancer survival model following radiotherapy
31. Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
32. Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study
33. Considerations for the Clinical Implementation of MR-Guided ART for H&N Cancer
34. Nomogram to predict duration of clinical benefit from nivolumab in platinum resistant, recurrent/metastatic head and neck squamous cell carcinoma.
35. 2754: Late patient reported toxicity outcomes for T1-2N0-1 hypopharynx carcinoma treated with IMRT/VMAT
36. The impact of gadolinium‐based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac
37. 66: Local Control in Tumour-Targeted Dose Escalation for Localized Prostate Cancer: A Report on the Target Study
38. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
39. P-55 Contemporary swallowing outcome for oropharynx carcinoma following definitive VMAT (chemo)radiotherapy
40. Identifying patients at risk of neutropenic sepsis: Sameena Khan and colleagues report on an initiative to ensure timely treatment of patients undergoing chemotherapy for urothelial malignancies who are at risk of developing infection
41. Prospective Evaluation of Patient-Reported Experiences with Adaptive Radiation Therapy on an MR-Linac
42. The impact of gadolinium‐based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac.
43. Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life
44. Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas
45. Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones
46. Improved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI data
47. Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus
48. Feeding tube dependency at 12 months post treatment in oropharyngeal cancer patient treated with radical intent- a single institute experience
49. Feeding tube dependency at 12 months post treatment in oropharyngeal cancer patient treated with radical intent – A single institute experience
50. Seminoma Patients with Retroperitoneal Disease: Does Better PTV Conformality Make VMAT the Better Treatment Choice?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.